Los puntos clave no están disponibles para este artículo en este momento.
In 1962, President Kennedy signed into law the Kefauver–Harris Amendments to the Federal Food, Drug, and Cosmetic Act. Many issues covered by provisions cut from the bill continue to confront those who would ensure access to innovative, safe, efficacious, affordable therapeutics.
Greene et al. (Thu,) studied this question.